US Patent Issued to QUIVER HOLDINGS on Jan. 20 for "Therapeutics for Syngap haploinsufficiency" (Massachusetts Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,057, issued on Jan. 20, was assigned to QUIVER HOLDINGS INC. (Cambridge, Mass.).

"Therapeutics for Syngap haploinsufficiency" was invented by Graham T. Dempsey (Sudbury, Mass.), Caitlin Lewarch (Cambridge, Mass.), Matt Mccabe (Cambridge, Mass.), James Fink (Cambridge, Mass.), David Gerber (Cambridge, Mass.) and Luis Williams (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to therapeutic compositions for disorders associated with haploinsufficiency. The invention provides antisense oligonucleotides useful for treating neurodevelopmental disorders associated with mutations in the SYNGAP gene. The invention provid...